We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Name | Symbol | Market | Type |
|---|---|---|---|
| Adaptimmune Therapeutics PLC | NASDAQ:ADAP | NASDAQ | Depository Receipt |
| Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 1.19 | 1.17 | 1.22 | 0 | 12:00:05 |
From May 2022 to May 2024
By Denny Jacob
International stocks trading in New York closed higher on Friday.
The S&P/BNY Mellon index of American depositary receipts edged up 2.3% to 134.68. The European index moved up 2.3% to 125.78. The Asian index rose 2.1% to 162.86. The Latin American index gained 3% to 188.80, while the emerging-markets index advanced 2.2% to 282.18.
Argo Blockchain PLC was among those whose ADRs traded actively.
The cryptocurrency miner rose 14% after the company said it mined 235 bitcoin or bitcoin equivalents last month, compared with 219 bitcoin or bitcoin equivalents in July, it said in a filing with the Securities and Exchange Commission.
Novel cancer immunotherapy products developer Adaptimmune Therapeutics Plc tumbled 5.9% despite issuing positive data from its signal-finding Phase 1 SURPASS trial.
Write to Denny Jacob at denny.jacob@wsj.com
(END) Dow Jones Newswires
September 09, 2022 17:47 ET (21:47 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.
1 Year Adaptimmune Therapeutics Chart |
1 Month Adaptimmune Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
